Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy
Nina Kimer, Aleksander Krag,
Lise L Gluud
17
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Rifaximin
100%
Hepatic Encephalopathy
78%
Patient Safety
64%
Lactulose
44%
Ammonia
37%
Branched Chain Amino Acids
21%
Coma
17%
Duration of Therapy
15%
Liver Cirrhosis
15%
Cognitive Dysfunction
13%
Poisons
12%
Bacteria
11%
Retrospective Studies
11%
Anti-Bacterial Agents
10%
Therapeutics
10%
Clinical Trials
10%
Safety
9%
Social Sciences
Clinical Trials
23%